289 related articles for article (PubMed ID: 12131349)
21. Expression of CD44s and CD44 splice variants in human melanoma.
Ranuncolo SM; Ladeda V; Gorostidy S; Morandi A; Varela M; Lastiri J; Loria D; Del Aguila R; Joffé EB; Pallotta G; Puricelli L
Oncol Rep; 2002; 9(1):51-6. PubMed ID: 11748454
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathologic significance of expression of CD44s and CD44v6 isoforms in squamous cell carcinoma of the supraglottic larynx.
Rodrigo JP; Domínguez F; Alvarez C; González MV; Herrero A; Suárez C
Am J Clin Pathol; 2002 Jul; 118(1):67-72. PubMed ID: 12109858
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of p53 expression in Wilms' tumor in children.
Skotnicka-Klonowicz G; Kobos J; Łoś E; Trejster E; Szymik-Kontorowicz S; Daszkiewicz P
Med Sci Monit; 2001; 7(6):1224-9. PubMed ID: 11687734
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of CD44 isoform expression in thymic epithelial neoplasms.
Sonobe S; Miyamoto H; Nobukawa B; Izumi H; Futagawa T; Ishikawa N; Yamazaki A; Uekusa T; Abe H; Suda K
Cancer; 2005 May; 103(10):2015-22. PubMed ID: 15830350
[TBL] [Abstract][Full Text] [Related]
25. Over expression of CD44V8-10 in urinary exfoliated cells as an independent prognostic predictor in patients with urothelial cancer.
Miyake H; Eto H; Arakawa S; Kamidono S; Hara I
J Urol; 2002 Mar; 167(3):1282-7. PubMed ID: 11832714
[TBL] [Abstract][Full Text] [Related]
26. Expression of CD44 splice variant v10 in Hodgkin's disease is associated with aggressive behaviour and high risk of relapse.
Beham-Schmid C; Heider KH; Hoefler G; Zatloukal K
J Pathol; 1998 Dec; 186(4):383-9. PubMed ID: 10209487
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of the heat shock protein 70 in the histological compartments of nephroblastomas.
Efferth T; Schulten HG; Thelen P; Bode ME; Beniers AJ; Granzen B; Ringert RH; Mertens R; Gefeller O; Jakse G; Fuzesi L
Anticancer Res; 2001; 21(4B):2915-20. PubMed ID: 11712786
[TBL] [Abstract][Full Text] [Related]
28. Expression of E-cadherin, and CD44s and CD44v6 and its association with prognosis in head and neck cancer.
Kawano T; Nakamura Y; Yanoma S; Kubota A; Furukawa M; Miyagi Y; Tsukuda M
Auris Nasus Larynx; 2004 Mar; 31(1):35-41. PubMed ID: 15041052
[TBL] [Abstract][Full Text] [Related]
29. Expression and prognostic value of the CD44 splicing variants v5 and v6 in gastric cancer.
Müller W; Schneiders A; Heider KH; Meier S; Hommel G; Gabbert HE
J Pathol; 1997 Oct; 183(2):222-7. PubMed ID: 9390037
[TBL] [Abstract][Full Text] [Related]
30. Differential expression of the drug resistance markers DNA topoisomerase II alpha and glutathione S-transferase-pi in the histological compartments of Wilms' tumors.
Granzen B; Efferth T; Keller U; Beniers AJ; Mertens R; Jakse G; Füzesi L
Anticancer Res; 2001; 21(1B):771-6. PubMed ID: 11299842
[TBL] [Abstract][Full Text] [Related]
31. Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation.
Terpe HJ; Störkel S; Zimmer U; Anquez V; Fischer C; Pantel K; Günthert U
Am J Pathol; 1996 Feb; 148(2):453-63. PubMed ID: 8579108
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of CD44s expression in biliary tract cancers.
Lee SM; Lee KE; Chang HJ; Choi MY; Cho MS; Min SK; Lee HK; Mun YC; Nam EM; Seong CM; Lee SN
Ann Surg Oncol; 2008 Apr; 15(4):1155-60. PubMed ID: 18214619
[TBL] [Abstract][Full Text] [Related]
33. The prognostic significance of CD44s and CD44v6 expression in stage two breast carcinoma: an immunohistochemical study.
Morris SF; O'Hanlon DM; McLaughlin R; McHale T; Connolly GE; Given HF
Eur J Surg Oncol; 2001 Sep; 27(6):527-31. PubMed ID: 11520083
[TBL] [Abstract][Full Text] [Related]
34. Expression of CD44 variant isoforms in malignant melanoma.
Seiter S; Schadendorf D; Herrmann K; Schneider M; Rösel M; Arch R; Tilgen W; Zöller M
Clin Cancer Res; 1996 Mar; 2(3):447-56. PubMed ID: 9816190
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of survivin expression in Wilms tumor.
Basta-Jovanovic G; Radojevic-Skodric S; Brasanac D; Djuricic S; Milasin J; Bogdanovic L; Opric D; Savin M; Baralic I; Jovanovic M
J BUON; 2012; 17(1):168-73. PubMed ID: 22517713
[TBL] [Abstract][Full Text] [Related]
36. p53 immunopositivity in histologically favorable Wilms tumor is not related to stage at presentation or to biological aggression.
D'Angelo MF; Kausik SJ; Sebo TJ; Rathbun SR; Kramer SA; Husmann DA
J Urol; 2003 May; 169(5):1815-7. PubMed ID: 12686851
[TBL] [Abstract][Full Text] [Related]
37. Increased tissue factor expression and poor nephroblastoma prognosis.
Maciel EO; Carvalhal GF; da Silva VD; Batista EL; Garicochea B
J Urol; 2009 Oct; 182(4):1594-9. PubMed ID: 19683742
[TBL] [Abstract][Full Text] [Related]
38. Alpha-fetoprotein producing tumor cells in children with Wilms' tumor.
Kesik V; Ozcan A; Sari E; Guven A; Kismet E; Koseoglu V
Fetal Pediatr Pathol; 2010; 29(3):127-32. PubMed ID: 20450265
[TBL] [Abstract][Full Text] [Related]
39. Quantitative assessment of expression of cell adhesion molecule (CD44) splice variants: CD44 standard (CD44s) and v5, v6 isoforms in oral leukoplakias: an immunohistochemical study.
Godge PY; Poonja LS
Indian J Dent Res; 2011; 22(3):493-4. PubMed ID: 22048598
[TBL] [Abstract][Full Text] [Related]
40. Expression of the hyaluronan receptor, CD44S, in epithelial ovarian cancer is an independent predictor of survival.
Kayastha S; Freedman AN; Piver MS; Mukkamalla J; Romero-Guittierez M; Werness BA
Clin Cancer Res; 1999 May; 5(5):1073-6. PubMed ID: 10353740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]